Setting a new standard in the 3D printing industry by developing antibacterial nanocomposites that fight bacteria for printed prosthetics.

10% of all patients admitted in a hospital will get a Hospital-Acquired Infection. Copper3D is revolutionizing the 3D printing industry with a patented and highly effective additive based on copper nanoparticles to "hack" materials and transform them into fully antimicrobial. Copper3D's first product is now available: a high quality PLA polymer called PLACTIVE, which eliminates a wide range of microorganisms. They also developed a medical-grade material called NANOCLEAN, a PETG polymer with additive concentration of 1% aimed at more specific purposes in medical devices. Copper3D's printing materials, as well as objects 3D printed with Copper3D's materials, have been tested and validated by the Microbiology Laboratory of the Universidad Católica de Valparaíso, Chile, and the laboratory SITU Biosciences in the U.S.
PLACTIVE was also clinically tested in 3D printed prosthetics for U.S. war veterans and currently is tested by NASA for 3D printed applications in long term space missions.
This new breed of "Active Materials" will transform several industries from Healthcare, Medical Devices, Food, Animal Care, Aerospace, among others.

FOUNDED
2018

AREAS OF IMPACT
Health

HEADQUARTERS
Santiago, Santiago Metropolitan Region, Chile

COMPANY SIZE
500+

Daniel Martínez

Daniel Martínez (Co-Founder & Director of Innovation at Copper3D) has been an Unreasonable Fellow since November 2018 after participating in Unreasonable Goals 2018.

Unreasonable Goals 2018

Connect with Copper3D

Follow Copper3D on social media below.

  • Featured VentureUncommon Cacao

  • Featured VentureElvis & Kresse